The initiative aims to equip pharmaceutical companies, biotech firms and research institutions with AI-driven molecular analysis tools to accelerate drug discovery and advance computational biology research.
Vecura | 17/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy